Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1

Journal of Biological Chemistry

Volumn 288, Issue 1, 2013, Pages 332-342

  Scilabra, Simone D ^a   Troebergs, Linda ^a   Yamamoto, Kazuhiro ^a   Emonard, Hervé ^b   Thgøersen, Ida ^c   Enghild, Jan J ^c   Strickland, Dudley K ^d   Nagases, Hideaki ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMALYSINS; CELL SURFACES; CELL TYPES; CELLULAR UPTAKE; CHONDROCYTES; CHONDROSARCOMA CELLS; CONCENTRATION-DEPENDENT; DIFFERENTIAL REGULATION; EXTRACELLULAR; EXTRACELLULAR LEVELS; EXTRACELLULAR MATRICES; EXTRACELLULAR SPACE; INHIBITORY ACTIVITY; LOW DENSITY LIPOPROTEINS; MATRIX METALLOPROTEINASES; MEMBRANE-BOUND; METALLOPROTEINASES; THROMBOSPONDIN MOTIFS; TISSUE INHIBITOR;

BIOCHEMISTRY; BODY FLUIDS; CELL CULTURE; CELL MEMBRANES; ENZYME INHIBITION; MOLECULAR BIOLOGY; PROTEINS;

TISSUE;

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL COUNT; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CHO CELLS; CRICETINAE; ENDOCYTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPARITIN SULFATE; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; PHENOTYPE; SYNDECAN-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84872079540     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.393322     Document Type: Article

References (58)

1. Brew, K., and Nagase, H. (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803, 55-71
2. Staskus, P. W., Masiarz, F. R., Pallanck, L. J., and Hawkes, S. P. (1991) The 21-kDa protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts. J. Biol. Chem. 266, 449-454 (Pubitemid 21906142)
3. Yu, W. H., Yu, S., Meng, Q., Brew, K., and Woessner, J. F. (2000) TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J. Biol. Chem. 275, 31226-31232
4. Leco, K. J., Waterhouse, P., Sanchez, O. H., Gowing, K. L., Poole, A. R., Wakeham, A., Mak, T. W., and Khokha, R. (2001) Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J. Clin. Invest. 108, 817-829 (Pubitemid 32884192)
5. Fedak, P. W., Smookler, D. S., Kassiri, Z., Ohno, N., Leco, K. J., Verma, S., Mickle, D. A., Watson, K. L., Hojilla, C. V., Cruz, W., Weisel, R. D., Li, R. K., and Khokha, R. (2004) TIMP-3 deficiency leads to dilated cardiomyopathy. Circulation 110, 2401-2409 (Pubitemid 39407346)
6. Fata, J. E., Leco, K. J., Voura, E. B., Yu, H. Y., Waterhouse, P., Murphy, G., Moorehead, R. A., and Khokha, R. (2001) Accelerated apoptosis in the TIMP-3-deficient mammary gland. J. Clin. Invest. 108, 831-841 (Pubitemid 32880292)
7. Sahebjam, S., Khokha, R., and Mort, J. S. (2007) Increased collagen and aggrecan degradation with age in the joints of Timp3-/- mice. Arthritis Rheum. 56, 905-909 (Pubitemid 46399438)
8. -/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat. Genet. 36, 969-977
9. Martin, E. L., Moyer, B. Z., Pape, M. C., Starcher, B., Leco, K. J., and Veldhuizen, R. A. (2003) Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1222-1232 (Pubitemid 37448793)
10. Cardellini, M., Menghini, R., Martelli, E., Casagrande, V., Marino, A., Rizza, S., Porzio, O., Mauriello, A., Solini, A., Ippoliti, A., Lauro, R., Folli, F., and Federici, M. (2009) TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58, 2396-2401
11. Su, S., DiBattista, J. A., Sun, Y., Li, W. Q., and Zafarullah, M. (1998) Upregulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-β in articular chondrocytes is mediated by serine/threonine and tyrosine kinases. J. Cell Biochem. 70, 517-527 (Pubitemid 28357961)
12. Li, W. Q., and Zafarullah, M. (1998) Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms. J. Immunol. 161, 5000-5007 (Pubitemid 28492082)
13. Darnton, S. J., Hardie, L. J., Muc, R. S., Wild, C. P., and Casson, A. G. (2005) Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis. Int. J. Cancer 115, 351-358 (Pubitemid 40663737)
14. Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., and Krichevsky, A. M. (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 28, 5369-5380
15. Garofalo, M., Di Leva, G., Romano, G., Nuovo, G., Suh, S. S., Ngankeu, A., Taccioli, C., Pichiorri, F., Alder, H., Secchiero, P., Gasparini, P., Gonelli, A., Costinean, S., Acunzo, M., Condorelli, G., and Croce, C. M. (2009) miR- 221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16, 498-509
16. Wang, B., Hsu, S. H., Majumder, S., Kutay, H., Huang, W., Jacob, S. T., and Ghoshal, K. (2010) TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29, 1787-1797
17. Limana, F., Esposito, G., D'Arcangelo, D., Di Carlo, A., Romani, S., Melillo, G., Mangoni, A., Bertolami, C., Pompilio, G., Germani, A., and Capogrossi, M. C. (2011) HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS One 6, e19845
18. Troeberg, L., Fushimi, K., Khokha, R., Emonard, H., Ghosh, P., and Nagase, H. (2008) Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J. 22, 3515-3524
19. Strickland, D. K., Gonias, S. L., and Argraves, W. S. (2002) Diverse roles for the LDL receptor family. Trends Endocrinol. Metab. 13, 66-74 (Pubitemid 36740449)
20. Lillis, A. P., Mikhailenko, I., and Strickland, D. K. (2005) Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J. Thromb. Haemost. 3, 1884-1893 (Pubitemid 41716576)
21. Wygrecka, M., Wilhelm, J., Jablonska, E., Zakrzewicz, D., Preissner, K. T., Seeger, W., Guenther, A., and Markart, P. (2011) Shedding of low density lipoprotein receptor-related protein-1 in acute respiratory distress syndrome. Am. J. Respir. Crit Care Med. 184, 438-448
22. Selvais, C., Gaide Chevronnay, H. P., Lemoine, P., Dedieu, S., Henriet, P., Courtoy, P. J., Marbaix, E., and Emonard, H. (2009) Metalloproteinase- dependent shedding of low density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation. Endocrinology 150, 3792-3799
23. Liu, Q., Zhang, J., Tran, H., Verbeek, M. M., Reiss, K., Estus, S., and Bu, G. (2009) LRP1 shedding in human brain: roles of ADAM10 and ADAM17. Mol. Neurodegener. 4, 17
24. 191 region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J. Biol. Chem. 275, 29610-29617
25. Nielsen, M. S., Nykjaer, A., Warshawsky, I., Schwartz, A. L., and Gliemann, J. (1995) Analysis of ligand binding to the α2-macroglobulin receptor/lowdensity lipoprotein receptor-related protein: evidence that lipoprotein lipase and the carboxyl-terminal domain of the receptor-associated protein bind to the same site. J. Biol. Chem. 270, 23713-23719
26. Kashiwagi, M., Enghild, J. J., Gendron, C., Hughes, C., Caterson, B., Itoh, Y., and Nagase, H. (2004) Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J. Biol. Chem. 279, 10109-10119 (Pubitemid 38372615)
27. Troeberg, L., Fushimi, K., Scilabra, S. D., Nakamura, H., Dive, V., Thøgersen, I. B., Enghild, J. J., and Nagase, H. (2009) The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. Matrix Biol. 28, 463-469
28. Esko, J. D., Stewart, T. E., and Taylor, W. H. (1985) Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 82, 3197-3201 (Pubitemid 15029573)
29. Willnow, T. E., and Herz, J. (1994) Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas endotoxin A: evidence that this protein is required for uptake and degradation of multiple ligands J. Cell Sci. 107, 719-726
30. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Tsuzuki, S., Nakamura, E., Kusugami, K., Saito, H., and Muramatsu, T. (2000) Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J. Biol. Chem. 275, 5249-5252 (Pubitemid 30115150)
31. Gendron, C., Kashiwagi, M., Hughes, C., Caterson, B., and Nagase, H. (2003) TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors. FEBS Lett. 555, 431-436 (Pubitemid 37532588)
32. Quinn, K. A., Grimsley, P. G., Dai, Y. P., Tapner, M., Chesterman, C. N., and Owensby, D. A. (1997) Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J. Biol. Chem. 272, 23946-23951 (Pubitemid 27410977)
33. Echtermeyer, F., Baciu, P. C., Saoncella, S., Ge, Y., and Goetinck, P. F. (1999) Syndecan-4 core protein is sufficient for the assembly of focal adhesions and actin stress fibers. J. Cell Sci. 112, 3433-3441
34. Ahonen, M., Poukkula, M., Baker, A. H., Kashiwagi, M., Nagase, H., Eriksson, J. E., and Kähäri, V. M. (2003) Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 22, 2121-2134 (Pubitemid 36539562)
35. Gorovoy, M., Gaultier, A., Campana, W. M., Firestein, G. S., and Gonias, S. L. (2010) Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages. J. Leukocyte Biol. 88, 769-778
36. Selvais, C., D'Auria, L., Tyteca, D., Perrot, G., Lemoine, P., Troeberg, L., Dedieu, S., Noël, A., Nagase, H., Henriet, P., Courtoy, P. J., Marbaix, E., and Emonard, H. (2011) Cell cholesterol modulates metalloproteinase- dependent shedding of low density lipoprotein receptor-related protein-1 (LRP-1) and clearance function. FASEB J. 25, 2770-2781
37. von Arnim, C. A., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., Liu, C. X., Bacskai, B. J., Sever, S., Irizarry, M. C., Strickland, D. K., and Hyman, B. T. (2005) The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate. J. Biol. Chem. 280, 17777-17785 (Pubitemid 41389016)
38. Rozanov, D. V., Hahn-Dantona, E., Strickland, D. K., and Strongin, A. Y. (2004) The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J. Biol. Chem. 279, 4260-4268 (Pubitemid 38199013)
39. Quinn, K. A., Pye, V. J., Dai, Y. P., Chesterman, C. N., and Owensby, D. A. (1999) Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP). Exp. Cell Res. 251, 433-441 (Pubitemid 29431880)
40. Engelholm, L. H., List, K., Netzel-Arnett, S., Cukierman, E., Mitola, D. J., Aaronson, H., Kjøller, L., Larsen, J. K., Yamada, K. M., Strickland, D. K., Holmbeck, K., Danø, K., Birkedal-Hansen, H., Behrendt, N., and Bugge, T. H. (2003) uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion. J. Cell Biol. 160, 1009-1015 (Pubitemid 36443870)
41. Kjøller, L., Engelholm, L. H., Høyer-Hansen, M., Danø, K., Bugge, T. H., and Behrendt, N. (2004) uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV. Exp. Cell Res. 293, 106-116 (Pubitemid 38064418)
42. Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., and Strickland, D. K. (2001) The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276, 15498-15503
43. Emonard, H., Bellon, G., Troeberg, L., Berton, A., Robinet, A., Henriet, P., Marbaix, E., Kirkegaard, K., Patthy, L., Eeckhout, Y., Nagase, H., Hornebeck, W., and Courtoy, P. J. (2004) Low density lipoprotein receptorrelated protein mediates endocytic clearance of pro-MMP-2·TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 279, 54944-54951 (Pubitemid 40053241)
44. Stanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., and Esko, J. D. (2009) Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J. Clin. Invest. 119, 3236-3245
45. Wang, S., Herndon, M. E., Ranganathan, S., Godyna, S., Lawler, J., Argraves, W. S., and Liau, G. (2004) Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans. J. Cell. Biochem. 91, 766-776
46. Schwartz, A. L., and Broze, G. J., Jr. (1997) Tissue factor pathway inhibitor endocytosis. Trends Cardiovasc. Med. 7, 234-239 (Pubitemid 27459042)
47. Kanekiyo, T., Zhang, J., Liu, Q., Liu, C. C., Zhang, L., and Bu, G. (2011) Heparan sulphate proteoglycan and the low density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-β uptake. J. Neurosci. 31, 1644-1651
48. Sarafanov, A. G., Ananyeva, N. M., Shima, M., and Saenko, E. L. (2001) Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein. J. Biol. Chem. 276, 11970-11979
49. Neels, J. G., van Den Berg, B. M., Mertens, K., ter Maat, H., Pannekoek, H., van Zonneveld, A. J., and Lenting, P. J. (2000) Activation of factor IX zymogen results in exposure of a binding site for low density lipoprotein receptor-related protein. Blood 96, 3459-3465
50. Nilsson, S. K., Lookene, A., Beckstead, J. A., Gliemann, J., Ryan, R. O., and Olivecrona, G. (2007) Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 46, 3896-3904 (Pubitemid 46493490)
51. Westein, E., Denis, C. V., Bouma, B. N., and Lenting, P. J. (2002) The α-chains of C4b-binding protein mediate complex formation with lowdensity lipoprotein receptor-related protein. J. Biol. Chem. 277, 2511-2516 (Pubitemid 34953274)
52. Nykjaer, A., Petersen, C. M., Møller, B., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Munch, M., and Andreasen, P. A. (1992) Purified α2-macroglobulin receptor/LDL receptor-relatedprotein binds urokinase-plasminogen activator inhibitor type-1 complex: evidence that the α2-macroglobulin receptor mediates cellular degradationof urokinase receptor-bound complexes. J. Biol. Chem. 267, 14543-14546
53. Horn, I. R., van den berg, B. M., Moestrup, S. K., Pannekoek, H., and van Zonneveld, A. J. (1998) Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator. Thromb. Haemost. 80, 822-828
54. Stefansson, S., Muhammad, S., Cheng, X. F., Battey, F. D., Strickland, D. K., and Lawrence, D. A. (1998) Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. J. Biol. Chem. 273, 6358-6366 (Pubitemid 28144727)
55. Gandhi, N. S., and Mancera, R. L. (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72, 455-482
56. Fisher, C., Beglova, N., and Blacklow, S. C. (2006) Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol. Cell 22, 277-283
57. van den Biggelaar, M., Sellink, E., Klein Gebbinck, J. W., Mertens, K., and Meijer, A. B. (2011) A single lysine of the two-lysine recognition motif of the D3 domain of receptor-associated protein is sufficient to mediate endocytosis by low density lipoprotein receptor-related protein. Int. J. Biochem. Cell Biol. 43, 431-440
58. Arandjelovic, S., Hall, B. D., and Gonias, S. L. (2005) Mutation of lysine 1370 in full-length human α2-macroglobulin blocks binding to the lowdensity lipoprotein receptor-related protein-1. Arch Biochem. Biophys. 438, 29-35 (Pubitemid 40725205)